The authors showed that the experimental drug (STI571) Imatinib, sold under the brand names Gleevec and Glivec, 1) was well tolerated and had very significant antileukemic activity in patients with chronic myeloid leu…
The authors showed that the experimental drug (STI571) Imatinib, sold under the brand names Gleevec and Glivec, 1) was well tolerated and had very significant antileukemic activity in patients with chronic myeloid leu…